Insights

Access our latest insights & resources

Filters

Content Type: Research

MedTech: Near-term Threat of GLP-1 Agonists is Overblown

MedTech: Near-term Threat of GLP-1 Agonists is Overblown

Research, Fundamental
The market is concerned weight loss drugs (GLP-1 agonists) will...
Read more
CoStar Group Inc.: Initiating on a Leading Real Estate Services Provider

CoStar Group Inc.: Initiating on a Leading Real Estate Services Provider

Research, Fundamental
CoStar Group Inc. (CSGP) is the premier research database...
Read more
Winners & Losers from the UAW Strike

Winners & Losers from the UAW Strike

Research, Video, Fundamental
As of September 25, approximately 13% of the United Auto Workers’ (UAW) membership...
Read more
Anticipating Q4-ria

Anticipating Q4-ria

Research, Fundamental
As of the close on September 22, the S&P 500 declined 5.9% since July 31.
Read more
China’s Airlines: Promising Turnaround Clarity

China’s Airlines: Promising Turnaround Clarity

Research, Fundamental
Backed by pent-up domestic and inbound travel demand following the country’s full reopening...
Read more
Lowry Weekly ETF Commentary September 22, 2023

Lowry Weekly ETF Commentary September 22, 2023

Research, Technical
The wise Mahatma Gandhi once said “to lose patience is to lose the...
Read more
Lowry Mid-Week Commentary Week of September 20, 2023

Lowry Mid-Week Commentary Week of September 20, 2023

Research, Technical
While the major price indexes remain resilient, small-cap stocks have continued...
Read more
Hikes & Strikes

Hikes & Strikes

Research, Fundamental
Investors faced challenges last week, including higher inflation reports...
Read more
Lowry Weekly ETF Commentary Week of September 15, 2023

Lowry Weekly ETF Commentary Week of September 15, 2023

Research, Technical
Recent Lowry commentaries have focused on longer-term trends in areas with robust...
Read more
Life Science Tools and Services: Time to Be Selective Amid a Challenging H2 2023

Life Science Tools and Services: Time to Be Selective Amid a Challenging H2 2023

Research, Fundamental
Several Life Science Tools and Services (LSTS) companies had a tough Q2, negatively...
Read more